Intravenous Solution Market Overview
Intravenous solutions are administered to patients directly into the vein who are deficient in nutrients and are undergoing acute dehydration. They are prescribed to patients whose body fluid volume or body nutrient falls below the required level. The global intravenous solution market is likely to reach USD 11, 511.2 Mn by the end of 2028 at a CAGR of 7.69% over the forecast period of 2021-2028, asserts Market Research Future (MRFR) in an extensive study.
Intravenous solutions are believed to be more effective than oral ingestion and are relatively cost-effective than other treatment options which have spurred the adoption of administering drugs through the intravenous process and driven the global intravenous solutions market.The global Intravenous Solution Market derives much of its growth from the growing prevalence of chronic diseases. The occurrence of chronic diseases can result in a sudden loss of body fluids, and IV solutions can provide immediate replenishment of body fluids in such cases.
The factors which drive the market for intravenous (IV) solutions are cost-effectiveness, increasing prevalence of chronic diseases, the rise of cholera, and growing acceptance of vitamin C intravenous for colorectal cancer, increase in geriatric population, and increase in a number of dialysis patients, expanding healthcare expenditure and increasing government endorsement. Alterations in regulatory authorities’ reimbursement policies have motivated hospitals to explore different methods of administering drugs through the intravenous process.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1235
Intravenous Solution Market Segmentation
- The global intravenous (IV) solution market has been segmented based on type, nutritional content, and end user.
- By type, the global intravenous (IV) solution market has been segmented into total parenteral solution and peripheral parenteral solution.
- By nutritional content, the global intravenous (IV) solution market has been segmented into amino acid solution, carbohydrates, vitamins minerals, parenteral lipid emulsion, and
- By end user, the global intravenous (IV) solution market has been segmented into hospitals clinics, ambulatory and home care.
Intravenous Solution Market Regional Analysis
Geographically, the global intravenous solution market has been segmented into North America, Europe, Asia Pacific (APAC), and the Middle East Africa (MEA). North America is the largest market for intravenous solution and accounted for the largest share of the market in 2015. The growing prevalence of chronic diseases and greater acceptance of vitamin C intravenous solution for colorectal cancer is boosting the growth of the market. The North America intravenous solution market is likely to reach USD 6,543.4 Mn by the end of 2022.
Europe accounts for the second largest share of the global intravenous solution market and is likely to expand at a CAGR 8.12% over the forecast period.
APAC is poised to expand at the fastest rate of 8.34% over the forecast period. Improving healthcare infrastructure and growing demand for advanced and better treatment options drive the market in APAC.
Intravenous Solution Market Players
- Baxter International Inc. (US)
- Fresenius SE Co. KGaA (Germany)
- Braun Melsungen AG (Germany)
- ICU Medical Inc. (US)
- Pfizer Inc. (US)
- Grifols S.A. (Spain)
- Terumo Medical Corporation (Japan)
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/intravenous-solution-market-1235
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
